Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor Mira AldenJanuary 12, 2023
Flagship-Backed Biotech Uses Naturally-Occurring Molecules to Treat Chronic Disease Mira AldenDecember 13, 2022
Pharvaris, pushing through trial pause, sees shares surge with new study results Mira AldenDecember 9, 2022
Novartis prostate cancer drug succeeds in study key to company’s sales hopes Mira AldenDecember 5, 2022
